Fosaprepitant and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Fosaprepitant and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant-Insulin degludec
- Fosaprepitant-Insulin Degludec (U-100) Prefilled Pens
- Fosaprepitant-Insulin Degludec (U-100) Vials
- Fosaprepitant-Insulin Degludec (U-200) Prefilled Pens
- Fosaprepitant-Insulin degludec and liraglutide
- Fosaprepitant-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Fosaprepitant Injection
- Insulin aspart, recombinant Subcutaneous-Fosaprepitant Intravenous
- Insulin aspart, recombinant Subcutaneous-Foscarnet
- Insulin aspart, recombinant Subcutaneous-Foscarnet Intravenous
- Insulin aspart, recombinant Subcutaneous-Foscarnet Sodium
- Insulin aspart, recombinant Subcutaneous-Foscavir